Blog Post | Biologics and Reactivating Hepatitis: What is the Risk?
Friday, July 28, 2017
"A recent study sought to evaluate the safety profile of biologic therapies among psoriasis patients with concurrent positive serology for HBV or HCV.”
Read Full Blog on Dermcast.tv
|
|
Email to a Friend